GSK (LON:GSK) Given "Hold" Rating at Deutsche Bank Aktiengesellschaft

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Deutsche Bank Aktiengesellschaft restated their hold rating on shares of GSK (LON:GSK - Free Report) in a research note released on Thursday, MarketBeat Ratings reports. The firm currently has a GBX 1,450 ($19.25) price objective on the stock.

A number of other research firms also recently commented on GSK. JPMorgan Chase & Co. reiterated an "underweight" rating on shares of GSK in a research report on Friday, July 18th. Shore Capital reiterated a "buy" rating and set a GBX 2,000 ($26.55) target price on shares of GSK in a research report on Wednesday. Finally, Berenberg Bank reiterated a "hold" rating and set a GBX 1,600 ($21.24) target price on shares of GSK in a research report on Friday, July 18th.

GSK Price Performance

GSK stock traded down GBX 21.50 ($0.29) during midday trading on Thursday, hitting GBX 1,396.50 ($18.54). The company's stock had a trading volume of 8,559,338 shares, compared to its average volume of 13,407,056. GSK has a 12 month low of GBX 1,242.50 ($16.49) and a 12 month high of GBX 1,678.68 ($22.28). The company has a quick ratio of 0.73, a current ratio of 0.81 and a debt-to-equity ratio of 114.64. The firm has a market capitalization of £56.67 billion, a price-to-earnings ratio of 22.56, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The company has a 50 day moving average of GBX 1,434.66 and a two-hundred day moving average of GBX 1,425.41.

GSK (LON:GSK - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported GBX 75.30 ($1.00) earnings per share for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. On average, analysts expect that GSK will post 175.980975 EPS for the current year.

Insider Buying and Selling

In related news, insider Emma Walmsley sold 5,473 shares of the firm's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of GBX 1,449 ($19.23), for a total value of £79,303.77 ($105,261.18). Also, insider Wendy Becker purchased 545 shares of the stock in a transaction that occurred on Friday, June 20th. The stock was bought at an average price of GBX 1,435 ($19.05) per share, with a total value of £7,820.75 ($10,380.61). Insiders purchased a total of 1,905 shares of company stock worth $2,732,835 over the last three months. 1.61% of the stock is owned by insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.